Stereotaxis(STXS)

Focus: Stereotaxis is a public medical device company specializing in surgical navigation systems for cardiac electrophysiology and interventional cardiology procedures. The company operates at modest scale with $27M in annual revenue and focuses on magnetic navigation-guided catheter technologies.

Unknown Cardiovascular Medical Devices Cardiology

Profile data last refreshed 9h ago · AI intelligence enriched 3w ago

Funding Stage

PUBLIC

Open Jobs

About Stereotaxis

AI assessmentNot Hiring

No open roles listed right now. Follow Stereotaxis to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

4/9 — Basic

Company HealthStrong

Pipeline

Mid-stage

1 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Revenue

$27M

Pipeline & Clinical Trials

Percutaneous coronary intervention

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT00994331Stereotaxis Computed Tomography (CT) Co-Registration Study

N/A

Help build intelligence for Stereotaxis

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Active innovation momentum: FDA approval and first US procedures for MAGiC platform announced April 2026, signaling regulatory success and market entry acceleration.
Emerging robotics expansion: Announced acquisition of Robocath in April 2026 positions the company to grow into surgical robotics, broadening technical and commercial scope.
Niche expertise in high-value procedures: Focus on complex cardiac ablation and coronary interventions serves cardiologists and electrophysiologists, offering deep clinical domain knowledge.

Watch Out For

Consistent losses with declining cash: Company posted $24M net loss in FY2025 on $27M revenue with cash declining from $20M to $12M, raising runway concerns.
Flat revenue and no hiring: FY2024 and FY2025 revenue both flat at $27M with zero active job openings, indicating stalled growth and limited career mobility.

Generated by Claude from Stereotaxis's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

catheter ablation using magnetic navigation

Tachycardia, Ventricular

N/A

Clinical Trials (1)

NCT02637947Comparison of VT Ablation Outcomes Using Remote MAGNETIC Navigation Versus Manual Approach in a Low LVEF Population

N/A

RF Ablation

Ventricular Tachycardia

N/A

Clinical Trials (1)

NCT01401608Stereotaxis Idiopathic Ventricular Tachycardia (VT) Study

N/A

MAGiC™

Arrhythmias, Cardiac

N/A

Clinical Trials (1)

NCT06019845The MAGiC™ Cardiac Ablation European Study

N/A

remote magnetic catheter navigation

Atrial Flutter

N/A

Clinical Trials (1)

NCT00560872Remote Magnetic Navigation For Cavotricuspid Isthmus Ablation

N/A

Circumferential pulmonary vein ablation

Pulmonary Vein Isolation, Ablation Time, Procedure Time, Freedom Form Atrial Fibrillation

N/A

Clinical Trials (1)

NCT01583075Pulmonary Vein Ablation of Atrial Fibrillation Using Magnetic Navigation: Single Ring Versus Circumferential Techniques

N/A

Epicardial mapping and/or ablation

Ventricular Tachycardia

N/A

Clinical Trials (1)

NCT04171479RMN Versus Manual Epicardial Retrospective PMCF

N/A

PowerAssert RF wire in crossing coronary in-stent chronic total occlusions

Coronary Artery Disease

PHASE_2

Clinical Trials (1)

NCT01131793PowerAssert Radio-Frequency (RF) Guidewire Coronary In-Stent Chronic Total Occlusion (CTO)

Phase 2

Vdrive Lasso navigation

Atrial Fibrillation

PHASE_3

Clinical Trials (1)

NCT01656772Vdrive Evaluation of Remote Steering and Testing in Lasso Electrophysiology Procedures Study

Phase 3

Magnetic irrigated ablation catheter

Ventricular Tachycardia

PHASE_4

Clinical Trials (1)

NCT00851279Stereotaxis Study To Obliterate Persistent Ventricular Tachycardia

Phase 4

Bi-ventricular lead placement

Cardiac Resynchronization Therapy

PHASE_4

Clinical Trials (1)

NCT00370474MAGNET CRT Feasibility - Efficiency of LV Lead Placement Comparing Conventional vs. Magnetic Guidance

Phase 4

Acute hemodynamic assessment using PV Loops

Heart Failure, Congestive

PHASE_4

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 1990

Portfolio: 11 clinical trials

Top TAs: Cardiovascular

Publications: 23 in PubMed

SEC Filings: 2 available

Therapeutic Area Focus

Cardiovascular

5 pipeline

Marketed

Pipeline

Financials (FY2025)

Revenue

$27M1%

R&D Spend

$10M(36%)5%

Net Income

-$24M

Cash

Research Publications(10)

Recent peer-reviewed publications with author affiliations at this company

Troubles in the Pocket: Evidence- and Experience-Based Multidisciplinary Expert Consensus Recommendations for Implantable Pulse Generator Placement and Management of Associated Inconveniences.

Current pain and headache reports

2026

PMID:42008196

Brainstem cavernous malformations: observation, microsurgical resection or stereotactic radiosurgery.